Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies

Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials

(2018) James Bussel et al.   AMERICAN JOURNAL OF HEMATOLOGY

A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP

(2018) Francesco Rodeghiero   BRITISH JOURNAL OF HAEMATOLOGY

Fostamatinib for persistent/chronic adult immune thrombocytopenia

(2018) Adrian Newland et al.   Immunotherapy

Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia

(2016) Ann Janssens et al.   ANNALS OF HEMATOLOGY

Population Pharmacokinetic and Pharmacodynamic Modeling of Lusutrombopag, a Newly Developed Oral Thrombopoietin Receptor Agonist, in Healthy Subjects

(2016) Takayuki Katsube et al.   CLINICAL PHARMACOKINETICS

Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis

(2016) Indraraj Umesh Doobaree et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Romiplostim Treatment in Adults with Immune Thrombocytopenia of Varying Duration and Severity

(2015) Ann Janssens et al.   ACTA HAEMATOLOGICA

Is ITP a thrombophilic disorder?

(2015) Francesco Rodeghiero   AMERICAN JOURNAL OF HEMATOLOGY

Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study

(2015) Adrian Newland et al.   BRITISH JOURNAL OF HAEMATOLOGY

Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim

(2015) Douglas B. Cines et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia

(2014) J. B. Bussel et al.   BLOOD

Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors

(2014) M. Ruggeri et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia

(2013) S. Boyle et al.   BLOOD

Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy

(2013) David J. Kuter et al.   BRITISH JOURNAL OF HAEMATOLOGY

An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP)

(2012) Yukari Shirasugi et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Platelet Kinetics in Idiopathic Thrombocytopenic Purpura Patients Treated with Thrombopoietin Receptor Agonists

(2012) Oliver Meyer et al.   TRANSFUSION MEDICINE AND HEMOTHERAPY

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

(2011) C. Neunert et al.   BLOOD

Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial

(2011) Yukari Shirasugi et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

(2010) F. Zaja et al.   BLOOD

Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database

(2010) A. Sarpatwari et al.   HAEMATOLOGICA

Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia

(2010) David J. Kuter et al.   NEW ENGLAND JOURNAL OF MEDICINE

A phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura

(2009) Yukari Shirasugi et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

(2008) F. Rodeghiero et al.   BLOOD

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

(2008) David J Kuter et al.   LANCET